Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells

被引:21
|
作者
Smagur, A. [1 ,2 ]
Mitrus, I. [1 ,2 ]
Giebel, S. [1 ,2 ]
Sadus-Wojciechowska, M. [1 ,2 ]
Najda, J. [1 ,2 ]
Kruzel, T. [1 ,2 ]
Czerw, T. [1 ,2 ]
Gliwinska, J. [2 ,3 ]
Prokop, M. [2 ,3 ]
Glowala-Kosinska, M. [1 ,2 ]
Chwieduk, A. [1 ,2 ]
Holowiecki, J. [1 ,2 ]
机构
[1] Maria Sklodowska Curie Mem Canc Ctr, Dept Bone Marrow Transplantat, PL-44101 Gliwice, Poland
[2] Inst Oncol, Gliwice Branch, Gliwice, Poland
[3] Maria Sklodowska Curie Mem Canc Ctr, Analyt & Clin Biochem Dept, PL-44101 Gliwice, Poland
关键词
autologous transplantation; cryopreservation; dimethyl sulphoxide; leukapheresis; peripheral blood hematopoietic stem and progenitor cells; UMBILICAL-CORD BLOOD; BONE-MARROW TRANSPLANTATION; LONG-TERM CRYOPRESERVATION; 10-PERCENT DIMETHYLSULFOXIDE; HEMATOLOGIC RECONSTITUTION; POSTTHAW VIABILITY; CD34(+) CELLS; CFU-GM; ENGRAFTMENT; 5-PERCENT;
D O I
10.1111/j.1423-0410.2012.01657.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives The procedure of autologous hematopoietic stem/progenitor cell transplantation requires cryopreservation. Addition of DMSO is necessary to secure the viability of such cells, but this solvent is potentially toxic to stem cells' recipient. 10% DMSO solution is used by the majority of transplant centres. The aim of our study was to test if DMSO concentration might be reduced without negative impact on cell recovery and clonogenicity. Materials and Methods Samples were prospectively collected from 20 patients. Small volumes of leukapheresis products were frozen with different cryoprotective mixtures, containing 10%, 7 center dot 5%, 5% and 2 center dot 5% DMSO, respectively. The quality of cryoprotective mixtures was evaluated based on recovery, viability and clonogenic potential of hematopoietic stem cells after defreezing. Results Reduction in DMSO concentration to 7 center dot 5% or lower was associated with decreased recovery of nucleated cells. In contrast, the number of colonies was highest for 7 center dot 5% DMSO with significant differences when compared to 10%DMSO solution. Conclusion Reduction in DMSO concentration from 10% to 7 center dot 5% may have favourable impact on hematopoietic recovery after autologous transplantation. The findings require confirmation in a clinical setting.
引用
收藏
页码:240 / 247
页数:8
相关论文
共 50 条
  • [1] Effect of Various Concentrations of Dimethyl Sulfoxide (DMSO) on Cell Recovery and Clonogenic Potential of Cryopreserved Peripheral Blood Hematopoietic Progenitors
    Smagur, Andrzej
    Mitrus, Iwona
    Giebel, Sebastian
    Sadus-Wojciechowska, Maria
    Najda, Jacek
    Kruzel, Tomasz
    Czerw, Tomasz
    Gliwinska, Joanna
    Prokop, Magdalena
    Glowala-Kosinska, Magdalena
    Chwieduk, Agata
    Holowiecki, Jerzy
    BLOOD, 2011, 118 (21) : 841 - 841
  • [2] Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia
    Avila Portillo, Luz Mabel
    Guzman, Juliana
    Rojas, Carolina
    Becerra, Andrea
    Avila, Jennifer
    Jaimes, Diego
    Ospino, Benjamin
    Gomez, Claudia
    Ignacio Madero, Jose
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 109 (02) : 151 - 154
  • [3] Viability and clonogenic potential of peripheral blood progenitor cells (PBPC): The effect of liquid storage time.
    Reems, JA
    Wiltbank, TB
    Xu, R
    Fujita, D
    BLOOD, 2000, 96 (11) : 379A - 379A
  • [4] Mobilising chemotherapy affects the recovery of clonogenic peripheral blood stem cells
    Schippa, M
    Falchi, L
    Rauco, A
    Desantis, G
    Merluzzi, M
    Ferrara, P
    Lugini, A
    Liberati, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S159 - S160
  • [5] Expansion of megakaryocyte clonogenic potential of fresh and cryopreserved hematopoietic stem cells from placental/umbilical cord blood.
    Lazzari, L
    Lucchi, S
    Giordano, R
    Montemurro, T
    Brasca, M
    Garcea, F
    Lecchi, L
    Rebulla, P
    Sirchia, G
    BLOOD, 1999, 94 (10) : 348B - 348B
  • [6] Impact of cryopreservation on hematopoietic progenitor stem cell dose and viability in autologous hematopoietic stem cell transplantation
    Budhathoki, U.
    Neupane, S.
    Poudyal, B.
    Tuladhar, S.
    Shrestha, S.
    Pyatha, R.
    CLINICA CHIMICA ACTA, 2022, 530 : S448 - S449
  • [7] Satisfactory recovery and viability of stem cells cryopreserved at high cell concentration
    Perseghin, P
    Epis, R
    Vigano, M
    Malacrida, A
    Pastorini, A
    Camerone, G
    TRANSFUSION SCIENCE, 1997, 18 (03): : 399 - 403
  • [8] Analysis of circulating hematopoietic progenitor cells after peripheral blood stem cell transplantation
    Mahmut, N
    Katayama, Y
    Takenaka, K
    Teshima, T
    Ohno, Y
    Imajyo, K
    Hara, M
    Shinagawa, K
    Ishimaru, F
    Ikeda, K
    Niiya, K
    Harada, M
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1999, 69 (01) : 36 - 42
  • [10] Absolute density of different sources of hematopoietic progenitor cells: Bone marrow, peripheral blood stem cell and umbilical cord blood
    Araujo, Anelise Bergmann
    Angeli, Melissa Helena
    Salton, Gabrielle Dias
    Furlan, Juliana Monteiro
    Schmalfuss, Tissiana
    Rohsig, Liane Marise
    CYTOTHERAPY, 2017, 19 (01) : 128 - 130